The effect of emodin, an anthraquinone derivative extracted from the roots of Rheum tanguticum, against herpes simplex virus in vitro and in vivo

Journal of Ethnopharmacology

Volumn 133, Issue 2, 2011, Pages 718-723

  Xiong, Hai Rong ^a   Luo, Jun ^b   Hou, Wei ^a   Xiao, Hong ^a   Yang, Zhan Qiu ^a  

^a WUHAN UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

Antiviral activity; Emodin; HSV infection; Rhubarb

Indexed keywords

ACICLOVIR; EMODIN; PLANT EXTRACT; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG ISOLATION; DRUG PURIFICATION; GANGLION; HEART; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; LIVER; MOUSE; NONHUMAN; PLANT ROOT; RHEUM TANGUTICUM; RHUBARB; SURVIVAL RATE; SURVIVAL TIME; TISSUE CULTURE CELL; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CHINA; EMODIN; ETHNOPHARMACOLOGY; HEP G2 CELLS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MEDICINE, CHINESE TRADITIONAL; MICE; MICE, INBRED BALB C; PHYTOTHERAPY; PLANT ROOTS; PLANTS, MEDICINAL; RHEUM; VIRUS REPLICATION;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; MUS; RHEUM TANGUTICUM; RHEUM X HYBRIDUM; SIMPLEXVIRUS;

EID: 78651402891     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.10.059     Document Type: Article

References (40)

1. L.J. Abu-Raddad, A.S. Magaret, C. Celum, A. Wald, I.M. Longini Jr.; S.G. Self, and L. Corey Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa PLoS One 3 2008 e2230
2. D.S. Alves, L. Perez-Fons, A. Estepa, and V. Micol Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin Biochemical Pharmacology 68 2004 549 561
3. D.O. Andersen, N.D. Weber, S.G. Wood, B.G. Hughes, B.K. Murray, and J.A. North In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives Antiviral Research 16 1991 185 196
4. K. Anuradha, H.M. Singh, K.V. Gopal, G.R. Rama Rao, T.V. Ramani, and J. Padmaja Herpes simplex virus 2 infection: a risk factor for HIV infection in heterosexuals Indian Journal of Dermatology, Venereology and Leprology 74 2008 230 233
5. D.L. Barnard, J.H. Huffman, J.L. Morris, S.G. Wood, B.G. Hughes, and R.W. Sidwell Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus Antiviral Research 17 1992 63 77
6. R. Battistutta, S. Sarno, E. De Moliner, E. Papinutto, G. Zanotti, and L.A. Pinna The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2 The Journal of Biological Chemistry 275 2000 29618 29622
7. R.C. Brady, and D.I. Bernstein Treatment of herpes simplex virus infections Antiviral Research 61 2004 73 81
8. C.L. Celum The interaction between herpes simplex virus and human immunodeficiency virus Herpes 11 Suppl. 1 2004 36A 45A
9. C. Celum, R. Levine, M. Weaver, and A. Wald Genital herpes and human immunodeficiency virus: double trouble Bulletin of the World Health Organization 82 2004 447 453
10. C.L. Celum, N.J. Robinson, and M.S. Cohen Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection The Journal of Infectious Diseases 191 Suppl. 1 2005 S107 S114
11. A. Chakrabarty, K.R. Pang, J.J. Wu, J. Narvaez, M. Rauser, D.B. Huang, K.R. Beutner, and S.K. Tyring Emerging therapies for herpes viral infections (types 1-8) Expert Opinion on Emerging Drugs 9 2004 237 256
12. C.Y. Chen, R.C. Ballard, C.M. Beck-Sague, Y. Dangor, F. Radebe, S. Schmid, J.B. Weiss, V. Tshabalala, G. Fehler, Y. Htun, and S.A. Morse Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection Sexually Transmitted Diseases 27 2000 21 29
13. P.A. Cohen, J.B. Hudson, and G.H. Towers Antiviral activities of anthraquinones, bianthrones and hypericin derivatives from lichens Experientia 52 1996 180 183
14. A. Greco, J.J. Diaz, D. Thouvenot, and F. Morfin Novel targets for the development of anti-herpes compounds Infectious Disorders Drug Targets 7 2007 11 18
15. T.Y. Ho, S.L. Wu, J.C. Chen, C.C. Li, and C.Y. Hsiang Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction Antiviral Research 74 2007 92 101
16. W. Hou, Z.Q. Yang, K.L. Chen, J.J. Yang, W.H. Wang, H. Xiao, and L. Cheng Study of emodin against herpes simplex virus in vitro Chinese Journal of Pharmaceutical Analysis 23 2003 259 262
17. C.Y. Hsiang, and T.Y. Ho Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures British Journal of Pharmacology 155 2008 227 235
18. C.Y. Hsiang, C.L. Hsieh, S.L. Wu, I.L. Lai, and T.Y. Ho Inhibitory effect of anti-pyretic and anti-inflammatory herbs on herpes simplex virus replication The American Journal of Chinese Medicine 29 2001 459 467
19. Q. Huang, G. Lu, H.M. Shen, M.C. Chung, and C.N. Ong Anti-cancer properties of anthraquinones from rhubarb Medicinal Research Reviews 27 2007 609 630
20. G. Kleymann Agents and strategies in development for improved management of herpes simplex virus infection and disease Expert Opinion on Investigational Drugs 14 2005 135 161
21. L.V. Kovalchuk, L.V. Gankovskaya, O.A. Gankovskaya, and V.F. Lavrov Herpes simplex virus: treatment with antimicrobial peptides Advances in Experimental Medicine and Biology 601 2007 369 376
22. S. Leflore, P.L. Anderson, and C.V. Fletcher A risk-benefit evaluation of acyclovir for the treatment and prophylaxis of herpes simplex virus infections Drug Safety: An International Journal of Medical Toxicology and Drug Experience 23 2000 131 142
23. P. Mayaud, N. Nagot, I. Konate, A. Ouedraogo, H.A. Weiss, V. Foulongne, M.C. Defer, A. Sawadogo, M. Segondy, and P. Van de Perre Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women Sexually Transmitted Infections 84 2008 332 337
24. F.X. Mbopi-Keou, G. Gresenguet, P. Mayaud, H.A. Weiss, R. Gopal, M. Matta, J.L. Paul, D.W. Brown, R.J. Hayes, D.C. Mabey, and L. Belec Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention The Journal of Infectious Diseases 182 2000 1090 1096
25. D. Meruelo, G. Lavie, and D. Lavie Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin Proceedings of the National Academy of Sciences of the United States of America 85 1988 5230 5234
26. S.B. Mostad, J.K. Kreiss, A.J. Ryncarz, K. Mandaliya, B. Chohan, J. Ndinya-Achola, J.J. Bwayo, and L. Corey Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency The Journal of Infectious Diseases 181 2000 58 63
27. C.M. Nadelman, and V.D. Newcomer Herpes simplex virus infections. New treatment approaches make early diagnosis even more important Postgraduate Medicine 107 2000 189 195 199-200
28. A.R. Patel, P. Romanelli, B. Roberts, and R.S. Kirsner Treatment of herpes simplex virus infection: rationale for occlusion Advances in Skin & Wound Care 20 2007 408 412
29. J. Rajcani, and V. Durmanova Developments in herpes simplex virus vaccines: old problems and new challenges Folia Microbiologica 51 2006 67 85
30. S. Ramachandran, and P.R. Kinchington Potential prophylactic and therapeutic vaccines for HSV infections Current Pharmaceutical Design 13 2007 1965 1973
31. R.F. Schinazi, C.K. Chu, J.R. Babu, B.J. Oswald, V. Saalmann, D.L. Cannon, B.F. Eriksson, and M. Nasr Anthraquinones as a new class of antiviral agents against human immunodeficiency virus Antiviral Research 13 1990 265 272
32. S.J. Semple, S.M. Pyke, G.D. Reynolds, and R.L. Flower In vitro antiviral activity of the anthraquinone chrysophanic acid against poliovirus Antiviral Research 49 2001 169 178
33. P.M. Sheth, S. Sunderji, L.Y. Shin, A. Rebbapragada, S. Huibner, J. Kimani, K.S. Macdonald, E. Ngugi, J.J. Bwayo, S. Moses, C. Kovacs, M. Loutfy, and R. Kaul Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation The Journal of Infectious Diseases 197 2008 1394 1401
34. D. Shuangsuo, Z. Zhengguo, C. Yunru, Z. Xin, W. Baofeng, Y. Lichao, and C. Yan'an Inhibition of the replication of hepatitis B virus in vitro by emodin Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 12 2006 BR302 BR306
35. R.J. Sydiskis, D.G. Owen, J.L. Lohr, K.H. Rosler, and R.N. Blomster Inactivation of enveloped viruses by anthraquinones extracted from plants Antimicrobial Agents and Chemotherapy 35 1991 2463 2466
36. J. Tang, J.M. Colacino, S.H. Larsen, and W. Spitzer Virucidal activity of hypericin against enveloped and non-enveloped DNA and RNA viruses Antiviral Research 13 1990 313 325
37. D. Us Herpes simplex virus vaccine studies: from past to present Mikrobiyoloji Bulteni 40 2006 413 433
38. Z.Y. Wang, B. Xu, Y.Y. Song, G.T. Wang, H.Z. Xu, X.F. Wang, Y.L. Xue, Z.Y. Wang, and X.P. Yu Inhibition effects of rhubarb ethanol extract on herpes simplex virus infection in vivo Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 17 2003 169 173
39. M. Ye, J. Han, H. Chen, J. Zheng, and D. Guo Analysis of phenolic compounds in rhubarbs using liquid chromatography coupled with electrospray ionization mass spectrometry Journal of the American Society for Mass Spectrometry 18 2007 82 91
40. H. Yim, Y.H. Lee, C.H. Lee, and S.K. Lee Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor Planta Medica 65 1999 9 13